The Silencing of LncRNA-H19 Decreases Chemoresistance of Human Glioma Cells to Temozolomide by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway [Retraction]

[This retracts the article DOI: 10.2147/OTT.S154339.].

Saved in:
Bibliographic Details
Published inOncoTargets and therapy Vol. 15; pp. 329 - 330
Main Authors Jia, Linwei, Tian, Yaohui, Chen, Yonghan, Zhang, Gang
Format Journal Article
LanguageEnglish
Published New Zealand Dove 01.04.2022
Dove Medical Press
Subjects
chemoresistance
emt
glioma
lncrna-h19
Retraction
temozolomide
wnt/β-catenin
Online AccessGet full text

Cover

More Information
Summary:[This retracts the article DOI: 10.2147/OTT.S154339.].
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
ISSN:1178-6930
1178-6930
DOI:10.2147/OTT.S369352